Glycoprotein IIb/IIIa receptor antagonists: are we ignoring the evidence.

Singh, Sandeep; Gopal, Ajay K; Bahl, V K

Singh, Sandeep; Gopal, Ajay K; Bahl, V K.

Indian Heart J ; 2005 May-Jun; 57(3): 201-9

Article in English | IMSEAR | ID: sea-2892

Subject(s)

Angina, Unstable/diagnosis; Angioplasty, Balloon, Coronary/methods; Combined Modality Therapy; Electrocardiography; Emergency Treatment; Female; Humans; Male; Myocardial Infarction/diagnosis; Platelet Aggregation Inhibitors/administration & dosage; Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Thrombolytic Therapy/methods; Treatment Outcome

Fulltext

XML

Search on Google

Full text: Available Index: IMSEAR (South-East Asia) Main subject: Prognosis / Female / Humans / Male / Platelet Aggregation Inhibitors / Angioplasty, Balloon, Coronary / Randomized Controlled Trials as Topic / Survival Analysis / Thrombolytic Therapy / Sensitivity and Specificity Type of study: Controlled clinical trial / Diagnostic study / Etiology study / Prognostic study / Risk factors Language: English Journal: Indian heart j Year: 2005 Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google